Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Type of study
Language
Year range
1.
SQUMJ-Sultan Qaboos University Medical Journal. 2012; 12 (1): 33-40
in English | IMEMR | ID: emr-124447

ABSTRACT

The aim of this study was to compare the biochemical parameters, weight gain, osteopenia and phosphate supplementation in very low birth weight [VLBW] neonates receiving early versus late parenteral nutrition [EPN versus LPN]. A retrospective study was undertaken in the level III Neonatal Intensive Care Unit at Sultan Qaboos University Hospital, Oman: from January 2007 to October 2008 [LPN group, n = 47] and from January 2009 to June 2010 [EPN group, n = 44]. Demographic data, anthropometric and laboratory parameters were extracted from the electronic record system. The mean age of PN initiation was LPN = 47.3 hours versus EPN = 14.3 hours. Biochemical parameters analysed during the first week of life revealed a reduction in hypernatraemia [12.7% versus 6.8%] and non-oliguric hyperkalemia [12.7% versus 6.8%] in EPN, with no significant differences in acidosis and urea levels between the two groups. Hyperglycemia >12 mmol/L in <1000g was higher in EPN. Nutritional parameters in 81 babies who survived/stayed in the unit up to a corrected gestational age [CGA] of 34 weeks [40 in LPN and 41 in EPN], revealed a reduction in metabolic bone disease [osteopenia of prematurity [OOP], 17.5% versus 7.3%] and the need for phosphate supplementation [22.5% versus 7.3%] in the EPN group. There was no increase in acidosis or cholestasis. No difference was noted in albumin levels, time to full feeds, time to regain birthweight and mean weight gain per day till 34 weeks corrected CGA. EPN in VLBW newborns is well tolerated and reduces hypernatraemia, non-oliguric hyperkalemia, OOP and the need for phosphate supplementation


Subject(s)
Humans , Male , Female , Infant, Newborn , Parenteral Nutrition , Retrospective Studies , Hypernatremia , Hyperkalemia , Hyperglycemia , Bone Diseases, Metabolic , Phosphates
2.
SQUMJ-Sultan Qaboos University Medical Journal. 2010; 10 (1): 89-93
in English | IMEMR | ID: emr-98047

ABSTRACT

Caudal regression syndrome is a rare fetal condition of diabetic pregnancy. Although the exact mechanism is not known, hyperglycaemia during embryogenesis seems to act as a teratogen. Independently, caudal regression syndrome [CRS], agenesis of the corpus callosum [ACC] and partial lobar holoprosencephaly [HPE] have been reported in infants of diabetic mothers. To our knowledge, a combination of all these three conditions has not been reported so far


Subject(s)
Humans , Male , Infant, Newborn , Holoprosencephaly , Pregnancy in Diabetics , Hyperglycemia/complications , Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL